7745 PDF
7745 PDF
7745 PDF
org/joc
steve.davies@chem.ox.ac.uk
Received August 20, 2010
Sequential treatment of a 1,2-disubstituted olefin with m-CPBA, Br3CCO2H, and DBU results in the
one-pot, stereospecific conversion of the olefin to the corresponding disubstituted cyclic carbonate
(1,3-dioxolan-2-one). The reaction proceeds via an initial epoxidation followed by SN2-type epoxide
ring opening by Br3CCO2H and subsequent base-promoted carbonate formation upon elimination
of bromoform. When a solution of a secondary allylic or homoallylic amine and Br3CCO2H
is sequentially treated with m-CPBA then DBU, the product of the reaction is a cyclic carbamate
(1,3-oxazolidin-2-one or 1,3-oxazinan-2-one).
Introduction gas into an epoxide ring has been developed into an efficient
synthetic route.4
Cyclic carbonates are useful intermediates within organic
As part of an ongoing research program directed toward
synthesis1 and are often employed as protecting groups for
the chemo- and diastereoselective functionalization of allylic
1,2-diols.2 Interest in their synthesis has increased recently as
and homoallylic amines at the olefin,5 we have previously
they have been employed as polar aprotic solvents for a
developed an ammonium-directed olefinic oxidation of allylic
variety of reactions and as electrolytes for lithium ion
batteries.3 Methods for their preparation often rely on the
treatment of a 1,2-diol with phosgene (or an equivalent),2 (4) Coates, G. W.; Moore, D. R. Angew. Chem., Int. Ed. 2004, 43, 6618.
although more recently the metal-catalyzed insertion of CO2 Zhou, C.-H.; Beltramini, J. N.; Fana, Y. X.; Lu, G. Q. Chem. Soc. Rev. 2008,
37, 527.
(5) For examples of chemo- and diastereoselective cyclopropanations of
(1) Clements, J. H. Ind. Eng. Chem. Res. 2003, 42, 663. allylic amines from this laboratory, see: (a) Davies, S. G.; Ling, K. B.;
(2) Shaikh, A.-A. G.; Sivaram, S. Chem. Rev. 1996, 96, 951. Roberts, P. M.; Russell, A. J.; Thomson, J. E. Chem. Commun. 2007, 4029.
(3) Sch€
affner, B.; Sch€affner, F.; Verevkin, S. P.; B€
orner, A. Chem. Rev. (b) Csatayov a, K.; Davies, S. G.; Lee, J. A.; Ling, K. B.; Roberts, P. M.;
2010, 110, 4554. Russell, A. J.; Thomson, J. E. Tetrahedron 2010, 66, 8420.
DOI: 10.1021/jo101614f Published on Web 10/18/2010 J. Org. Chem. 2010, 75, 7745–7756 7745
r 2010 American Chemical Society
JOC Article Davies et al.
SCHEME 1a SCHEME 3a
a
Reagents and conditions: (i) Cl3CCO2H, m-CPBA, CH2Cl2, rt, 21 h,
then NaHCO3 (0.1 M, aq); (ii) K2CO3, MeOH, rt, 16 h.
SCHEME 2a
a
Reagents and conditions: (i) Cl3CCO2H, m-CPBA, CH2Cl2, rt, 21 h, a
Reagents and conditions: (i) Cl3CCO2H, m-CPBA, CH2Cl2, rt, 21 h,
then NaHCO3 (0.1 M, aq). then NaHCO3 (0.1 M, aq); (ii) Et3N, CH2Cl2, rt, 2 h; (iii) acid, m-CPBA,
CH2Cl2, rt, 18 h, then base, 0 °C to rt, 2 h (see table).
and homoallylic amines6 to facilitate the synthesis of amino
diol units.7 For instance, treatment of 3-N,N-dibenzylami-
nocyclohex-1-ene 1 with Cl3CCO2H followed by m-CPBA (i.e., those employed for 1, 4, and 5), oxidation of 8 resulted
and basic aqueous workup using NaHCO3 gave trichlo- in a 56:35:9 mixture of the regioisomeric trichloroacetate
roacetate ester 2 in 95:5 dr and quantitative yield. Tran- esters 9 and 10 and diol 11, with no trace of the correspond-
sesterification of 2 upon treatment with K2CO3 in MeOH ing cyclic carbonate 12. The absence of any cyclization
gives amino diol 3 in 95:5 dr and quantitative yield7a suggested that the presence of the amine function within 4
(Scheme 1). and 5 may have been important in promoting carbonate
Upon application of this protocol to bis- and trisho- formation. Indeed, when the mixture of trichloroacetate
moallylic amines 4 and 5 we noted that cyclic carbonates 6 esters 9 and 10 (and diol 11) was treated with Et3N in
and 7 were produced as the major products, rather than the CH2Cl2, conversion of both 9 and 10 to carbonate 12
expected trichloroacetate esters (Scheme 2).8 We were sur- occurred, and 12 was isolated in 52% yield after purification.
prised to note that this result represents only the second This transformation was next developed into a one-pot
reported example of the formation of a 1,3-dioxolan-2-one procedure for the formation of carbonate 12 from olefin 8:
upon treatment of an R-trichloroacetoxy alcohol with base9 the optimal protocol involved the treatment of allylbenzene 8
(in contrast, treatment of an R-trichloroacetamido alcohol with m-CPBA followed by Br3CCO2H, followed finally by
with base to form a 1,3-oxazolidin-2-one has been well the introduction of excess DBU to the reaction flask (as both
documented).10 In this light, we proposed that the transfor- a base and sacrificial reducing agent to scavenge any remain-
mation could be developed into a one-pot protocol for the ing peracid).11 These conditions proved more efficacious in
conversion of an olefin to a cyclic carbonate and delineate promoting carbonate formation than when employing either
herein the results of our studies in this area. F3CCO2H or Cl3CCO2H as the acid and/or than when
employing Et3N as both the reducing agent and base. No
Results and Discussion trihaloacetate ester products were observed in any of these
optimization studies, presumably due to in situ hydrolysis
One-Pot Conversion of Olefins to Cyclic Carbonates. The upon aqueous workup (Scheme 3).
application of our oxidation protocol to allylbenzene 8 (as a The mechanism and course of the reaction was followed by
model substrate) was examined. Under our literature conditions7a 1
H NMR spectroscopic analysis. Addition of m-CPBA to
allylbenzene 8 in CDCl3 promoted complete conversion of
starting material to epoxide 13 after 3 h. Subsequent addition
(6) We also developed a protocol for the diastereoselective oxidation of
the corresponding tertiary amine N-oxides; see: Aciro, C.; Davies, S. G.; of Br3CCO2H produced a 65:35 mixture of tribromoacetate
Kurosawa, W.; Roberts, P. M.; Russell, A. J.; Thomson, J. E. Org. Lett. esters 14 and 15 in quantitative conversion. When the
2009, 11, 1333. oxidation reaction was repeated using m-CPBA in the pres-
(7) (a) Aciro, C.; Claridge, T. D. W.; Davies, S. G.; Roberts, P. M.;
Russell, A. J.; Thomson, J. E. Org. Biomol. Chem. 2008, 6, 3751. (b) Aciro, C.; ence of Br3CCO2H, however, a reaction time of 7 h was
Davies, S. G.; Roberts, P. M.; Russell, A. J.; Smith, A. D.; Thomson, J. E. required before complete consumption of starting material
Org. Biomol. Chem. 2008, 6, 3762. (c) Bond, C. W.; Cresswell, A. J.; Davies,
S. G.; Kurosawa, W.; Lee, J. A.; Fletcher, A. M.; Roberts, P. M.; Russell, (to give a 65:35 mixture of tribromoacetate esters 14 and 15),
A. J.; Smith, A. D.; Thomson, J. E. J. Org. Chem. 2009, 74, 6735. (d) Bagal, indicating that the epoxidation reaction occurs faster in
S. K.; Davies, S. G.; Lee, J. A.; Roberts, P. M.; Russell, A. J.; Scott, P. M.; the absence of Br3CCO2H, presumably due to competitive
Thomson, J. E. Org. Lett. 2010, 12, 136.
(8) Although carbonate 7 could be isolated in pure form (84% yield), an
analytical sample of 6 could not be obtained even after exhaustive flash (10) For instance, see: Oishi, T.; Ando, K.; Inomiya, K.; Sato, H.; Iida,
column chromatography due to the presence of residual unidentified impu- M.; Chida, N. Org. Lett. 2002, 4, 151. Sakaguchi, H.; Tokuyama, H.;
rities (∼10%). Fukuyama, T. Org. Lett. 2007, 9, 1635. Shih, T.-L.; Li, H.-Y.; Ke, M.-S.;
(9) Bailey, S.; Helliwell, M.; Teerawutgulrag, A.; Thomas, E. J. Org. Kuo, W.-S. Synth. Commun. 2008, 38, 4139.
Biomol. Chem. 2005, 3, 3654. (11) Wefelscheid, U. K.; Woodward, S. J. Org. Chem. 2009, 74, 2254.
a
Reagents and conditions: (i) Br3CCO2H, m-CPBA, CDCl3, rt, 3 or
7 h; (ii) DBU, 0 °C to rt, 2 h.
SCHEME 5a
a
Reagents and conditions: (i) Br3CCO2H, CDCl3, rt, 12 h; (ii) K2CO3,
MeOH rt, 2 h.
SCHEME 10
a
Reagents and conditions: (i) Cl3CCO2H, m-CPBA, CH2Cl2, rt, 1 h
(R = Ph) or 21 h (R = iPr); (ii) Br3CCO2H, CDCl3, rt, 12 h; (iii) DBU, a
Reagents and conditions: (i) Br3CCO2H, m-CPBA, CH2Cl2, rt, 3 days,
CDCl3, 0 °C to rt, 1 h; (iv) Br3CCO2H, m-CPBA CH2Cl2, rt, 18 h, then then DBU, 0 °C to rt, 2 h.
DBU, 0 °C to rt, 2 h; (v) Cl3CCO2H, m-CPBA, CH2Cl2, 40 °C, 21 h;
(vi) K2CO3, MeOH, 60 °C 16 h. unambiguously established by single-crystal X-ray analysis;21
diol 77 was also prepared directly from allylic amine 67 upon
unambiguously by single-crystal X-ray analysis,19 and the treatment with m-CPBA in the presence of Cl3CCO2H at
relative configuration within 73 was assigned by analogy. 40 °C followed by transesterification (K2CO3/MeOH), con-
The stereochemical outcomes of these oxidation reactions sistent with a mechanism involving completely diastereose-
are therefore consistent with an ammonium-directed process lective epoxidation followed by completely regioselective
proceeding via transition state model 72 in which 1,3-allylic ring opening (Scheme 12).
strain is minimized. Treatment of a sample of epoxide 73 in It is noteworthy that even in the absence of significant 1,3-
CDCl3 with Br3CCO2H revealed quantitative conversion to allylic strain it is possible to obtain modest levels of diastereo-
tribromoacetate ester 75 as a single regio- and diastereo- selectivity within systems similar in structure to tertiary
isomer within 12 h. The connectivity within 75 was estab- allylic amines 67 and 68. For example, under optimized
lished by 1H NMR COSY and HMBC analyses. Subsequent conditions, sequential treatment of tertiary allylic amine 78
treatment of 75 with DBU gave quantitative conversion to with Br3CCO2H and m-CPBA at rt for 3 days followed by
carbonate 76 within 1 h. Interestingly, under analogous DBU gave a chromatographically inseparable 85:15 mixture
conditions, epoxide 74 showed a distinct recalcitrance to of carbonates 82 and 83,22 which were isolated in 77%
undergo ring opening upon treatment with Br3CCO2H, and combined yield. The relative configuration within the major
the use of more forcing conditions resulted only in starting diastereoisomeric carbonate 82 was assigned upon the as-
material degradation. In light of these results, application of sumption that the reaction proceeds by an analogous mech-
our previously optimized one-pot protocol for the formation anism to that delineated for 67, via epoxidation transition
of carbonates from allylic amines was investigated for 67, state model 79 that places the allylic C-H bond (i.e., C(1)H)
although this was found to give a 2:1 mixture of epoxide 73 of 78 coplanar with the olefinic C-H bond (i.e., C(3)H) to
(>99:1 dr) and carbonate 76 (>99:1 dr); when the reaction minimize allylic 1,3-strain (i.e., directly analogous to transi-
was repeated using 10 equiv of Br3CCO2H to promote the tion state model 72) to give the major epoxide diastereo-
ring-opening reaction, complete conversion to carbonate 76 isomer 80. Ring opening of the epoxide via an SN2-type
(>99:1 dr) was observed, and 76 was isolated in 90% yield as process at the carbon atom distal to the ammonium moiety
a single diastereoisomer whose relative configuration was
unambiguously assigned by single-crystal X-ray analysis;20 (21) Crystallographic data (excluding structure factors) have been depos-
this analysis also affirmed the regioselectivity of the epoxide ited with the Cambridge Crystallographic Data Centre as supplementary
ring-opening reaction [i.e., that formation of tribromoace- publication number CCDC 784952.
(22) The crude reaction mixture also contained an 85:15 mixture of diols
tate ester 75 from epoxide 73 occurs by preferential epoxide 84 and 85 (the ratio of carbonates 82 and 83 to diols 84 and 85 was 88:12);
ring opening distal to the ammonium moiety (as predicted) chromatography allowed isolation of the major diastereoisomeric diol 84 in
rather than via a process involving ring opening proximal to 7% yield and >99:1 dr, in addition to the 85:15 mixture of carbonates 82 and
83. The production of diols 84 and 85 in this reaction is presumably a result of
the ammonium moiety followed by migration of the tribro- competitive hydrolysis of the corresponding carbonates 82 and 83 or the
moacetate group]. Treatment of carbonate 76 with K2CO3 intermediate tribromoacetate esters. Treatment of an 85:15 mixture of
in MeOH gave diol 77 whose relative configuration was carbonates 82 and 83 with K2CO3 in MeOH gave an 85:15 mixture of diols
84 and 85.
130.8, 135.3 (o,m,p-Ar), 150.6 (i-Ar), 164.8 (CdO); m/z (ESIþ) 76.7 (C(40 )), 155.0 (C(20 )), 173.6 (C(1)); m/z (ESIþ) 225 ([M þ
402 ([M þ Na]þ, 90%); HRMS (ESIþ) C21H33NNaO5þ ([M þ Na]þ, 100%); HRMS (ESIþ) C9H14NaO5þ ([M þ Na]þ) requires
Na]þ) requires 402.2251; found 402.2252. 225.0733; found 225.0732.
(RS)-4-Phenyl-1,3-dioxolan-2-one 25. Following general (RS,RS)-4-Butyl-5-methyl-1,3-dioxolan-2-one 34. Following
qprocedure 1, 20 (105 mg, 1.00 mmol) in CH2Cl2 (6.7 mL) was general procedure 1, 30 (72 mg, 0.72 mmol) in CH2Cl2 (4.8 mL)
treated with Br3CCO2H (1.48 g, 5.00 mmol) and m-CPBA (344 was treated with Br3CCO2H (1.06 g, 3.61 mmol) and m-CPBA
mg, 75%, 1.50 mmol), followed by DBU (1.0 mL). Purification (250 mg, 75%, 1.08 mmol), followed by DBU (1.0 mL). Purifi-
via flash column chromatography (eluent 40-60 °C petrol/ cation via flash column chromatography (eluent 40-60 °C
EtOAc, 4:1) gave 25 as a colorless oil (103 mg, 63%):26 δH petrol/EtOAc, 5:1) gave 34 as a colorless oil (93 mg, 81%, >99:1 dr):
(400 MHz, CDCl3) 4.36 (1H, app t, J 8.4, C(5)HA), 4.81 (1H, app νmax (film) 2959 (C-H), 1802 (CdO); δH (400 MHz, CDCl3)
t, J 8.4, C(5)HB), 5.69 (1H, app t, J 8.4, C(4)H), 7.21-7.38 (5H, 0.89 (3H, t, J 6.5, C(40 )H3), 1.30-1.40 (4H, m, C(20 )H2, C(30 )H2),
m, Ph). 1.42 (3H, d, J 6.1, C(5)Me), 1.59-1.77 (2H, m, C(10 )H2), 4.16
(RS)-4-Decyl-1,3-dioxolan-2-one 26. Following general pro- (1H, dt, J 6.9, 5.1, C(4)H), 4.36 (1H, dq, J 6.9, 6.1, C(5)H); δC
cedure 1, 21 (151 mg, 0.90 mmol) in CH2Cl2 (6 mL) was treated (100 MHz, CDCl3) 13.7 (C(40 )), 19.0 (C(5)Me), 22.2 (C(20 )), 26.7
with Br3CCO2H (1.33 g, 4.50 mmol) and mCPBA (309 mg, 75%, (C(30 )), 32.8 (C(10 )), 78.4 (C(5)), 83.5 (C(4)), 154.6 (C(2)); m/z
1.35 mmol), followed by DBU (1.5 mL). Purification via flash (ESIþ) 181 ([M þ Na]þ, 100%); HRMS (ESIþ) C8H14NaO3þ
column chromatography (eluent 40-60 °C petrol/EtOAc 5:1) ([M þ Na]þ) requires 181.0835; found 181.0836.
gave 26 as a colorless oil (160 mg, 78%): νmax (film) 2925 (C-H), (RS,RS)-4-(Benzyloxymethyl)-5-propyl-1,3-dioxolan-2-one 35.
1800 (CdO), 1065; δH (400 MHz, CDCl3) 0.86 (3H, t, J 6.9, Following general procedure 1, 31 (190 mg, 1.00 mmol) in CH2Cl2
C(100 )H3), 1.22-1.36 (15H, m, CH2), 1.42-1.50 (1H, m, C(20 )- (6.6 mL) was treated with Br3CCO2H (1.48 g, 5.00 mmol) and m-
HA), 1.67-1.69 (1H, m, C(10 )HA), 1.77-1.89 (1H, m, C(10 )HB), CPBA (344 mg, 75%, 1.50 mmol), followed by DBU (1.5 mL).
4.07 (1H, t, J 8.5, C(5)HA), 4.52 (1H, t, J 8.5, C(5)HB), 4.67-4.72 Purification via flash column chromatography (eluent 40-60 °C
(1H, m, C(4)H); δC (100 MHz, CDCl3) 14.1 (C(100 )), 22.6, 24.3, petrol/EtOAc, 4:1) gave 35 as a colorless oil (185 mg, 74%,
29.1, 29.2, 29.3, 29.4, 29.5, 31.8 (C(20 )-C(90 )), 33.9 (C(10 )), 69.4 >99:1 dr): νmax (film) 2962 (C-H), 1797 (CdO); δH (500 MHz,
(C(4)), 76.7 (C(5)), 155.6 (C(2)); m/z (ESIþ) 251 ([M þ Na]þ, CDCl3) 0.96 (3H, t, J 7.0, C(300 )H3), 1.38-1.44 (1H, m, C(200 )HA),
100%); HRMS (ESIþ) C13H24NaO3þ ([M þ Na]þ) requires 1.57-1.66 (2H, m, C(200 )HB, C(100 )HA), 1.79-1.85 (1H, m,
251.1618; found 251.1616. C(100 )HB), 3.64-3.71 (2H, m, CH2OBn), 4.57-4.58 (2H, m,
(RS)-4-(Benzyloxymethyl)-1,3-dioxolan-2-one 27. Following OCH2Ph), 4.70-4.73 (2H, m, C(4)H, C(5)H), 7.30-7.45 (5H,
general procedure 1, 22 (107 mg, 0.72 mmol) in CH2Cl2 (4.8 mL) m, Ph); δC (125 MHz, CDCl3) 13.7 (C(300 )H3), 19.2 (C(200 )), 30.5
was treated with Br3CCO2H (1.06 g, 3.60 mmol) and m-CPBA (C(100 )), 66.7 (CH2OBn), 73.8 (CH2Ph), 76.7, 79.2 (C(4), C(5)),
(506 mg, 75%, 2.19 mmol), followed by DBU (1.0 mL). Purification 127.7, 128.0, 128.5 (o,m,p-Ph), 137.0 (i-Ph), 154.5 (C(2)); m/z
via flash column chromatography (eluent 40-60 °C petrol/EtOAc, (ESIþ) 273 ([M þ Na]þ, 90%); HRMS (ESIþ) C14H18NaO4þ
4:1) gave 27 as a colorless oil (94 mg, 63%):27 δH (400 MHz, ([M þ Na]þ) requires 273.1097; found 273.1095.
CDCl3) 3.62 (1H, dd, J 11.0, 3.7, CHAHBOBn), 3.71 (1H, dd, J (RS,RS)-5-(20 -Hydroxyethyl)-4-ethyl-1,3-dioxolan-2-one 36.
11.0, 3.7, CHAHBOBn), 4.38 (1H, dd, J 8.6, 6.2, C(5)HA), 4.48 Following general procedure 1, 32 (100 mg, 1.00 mmol) in
(1H, app t, J 8.6, C(5)HB), 4.58 (2H, AB system, J 12.2, OCH2Ph), CH2Cl2 (6.6 mL) was treated with Br3CCO2H (1.48 g, 5.00
4.79-4.84 (1H, m, C(4)H), 7.30-7.40 (5H, m, Ph). mmol) and m-CPBA (344 mg, 75%, 1.50 mmol), followed by
(RS)-4-(40 -Acetoxybutyl)-1,3-dioxolan-2-one 28. Following DBU (1.0 mL). Purification via flash column chromatography
general procedure 1, 23 (70 mg, 0.50 mmol) in CH2Cl2 (3.3 mL) (eluent 40-60 °C petrol/EtOAc, 1:1) gave 36 as a pale yellow oil
was treated with Br3CCO2H (740 mg, 2.5 mmol) and m-CPBA (83 mg, 65%, >99:1 dr): νmax (film) 3424 (O-H), 2972 (C-H),
(172 mg, 75%, 0.75 mmol), followed by DBU (1.0 mL). Purifi- 1790 (CdO); δH (400 MHz, CDCl3) 1.02 (3H, t, J 7.5, Me), 1.74
cation via flash column chromatography (eluent 40-60 °C (2H, q, J 7.5, C(100 )H2), 1.91-1.98 (2H, m, C(10 )H2), 3.78-3.81
petrol/EtOAc, 1:1) gave 28 as an opaque oil (85 mg, 84%): νmax (2H, m, C(20 )H2), 4.30 (1H, dd, J 12.6, 7.5, C(5)H), 4.47-4.52
(film) 2917 (C-H), 1793 (CdO, carbonate), 1731 (CdO, ester); (1H, m, C(4)H); δC (100 MHz, CDCl3) 8.8 (C(200 )), 26.5 (C(100 )),
δH (400 MHz, CDCl3) 1.41-1.50 (1H, m, CH2), 1.53-1.61 (1H, 36.2 (C(10 )), 57.9 (C(20 )), 79.1 (C(4)), 83.4 (C(5)), 155.0 (C(2));
m, CH2), 1.66-1.76 (4H, m, CH2), 2.04 (3H, s, COMe), 4.05- m/z (ESIþ) 183 ([M þ Na]þ, 100%); HRMS (ESIþ) C7H12NaO4þ
4.08 (3H, m, C(5)HA, C(40 )H2), 4.53 (1H, t, J 9.4, C(5)HB), ([M þ Na]þ) requires 180.0628; found 180.0636.
4.47-4.74 (1H, m, C(4)H); δC (100 MHz, CDCl3) 20.9 (Me), (RS,RS)-4-(20 -Dibenzylaminoethyl)-5-ethyl-1,3-dioxolan-2-one
21.1, 28.1, 33.5 (C(10 )-C(30 )), 63.7 (C(40 )), 69.3 (C(5)), 76.8 37. Following general procedure 2, 33 (279 mg, 1.00 mmol) in
(C(4)), 154.9 (C(2)), 171.1 (COMe); m/z (ESIþ) 225 ([M þ Na]þ, CH2Cl2 (6.6 mL) was treated with Br3CCO2H (1.48 g, 5.00 mmol)
100%); HRMS (ESIþ) C9H14NaO5þ ([M þ Na]þ) requires and m-CPBA (344 mg, 75%, 1.5 mmol), followed by DBU (1.0 mL).
225.0733; found 225.0732. Purification via flash column chromatography (eluent 40-60 °C
(RS)-Methyl 5-(10 ,30 -dioxolan-20 -one-40 -yl)pentanoate 29. petrol/EtOAc, 6:1) gave 37 as a colorless oil (252 mg, 74%,
Following general procedure 1, 24 (142 mg, 1.00 mmol) in CH2Cl2 >99:1 dr): νmax (film) 2969 (C-H), 1801 (CdO); δH (500 MHz,
(6.6 mL) was treated with Br3CCO2H (1.48 g, 5.00 mmol) and m- CDCl3) 0.98 (3H, t, J 7.4, C(200 )H3), 1.46-1.58 (2H, m, C(100 )H2),
CPBA (344 mg, 75%, 1.50 mmol), followed by DBU (1.0 mL). 1.71-1.86 (1H, m, C(10 )HA), 1.88-1.94 (1H, m, C(10 )HB), 2.59-
Purification via flash column chromatography (eluent 40-60 °C 2.63 (2H, m, C(20 )H2), 3.61 (4H, AB system, JAB 13.5, N(CH2-
petrol/EtOAc, 2:1) gave 29 as a yellow oil (143 mg, 71%): νmax Ph)2), 4.05-4.09 (1H, m, C(5)H), 4.28-4.32 (1H, m, C(4)H),
(film) 2917 (C-H), 1793 (CdO, carbonate), 1731 (CdO, ester); 7.26-7.34 (10H, m, Ph); δC (125 MHz, CDCl3) 8.9 (C(200 )H3),
δH (400 MHz, CDCl3) 1.38-1.59 (2H, m, C(4)H2), 1.64-1.86 26.5 (C(100 )H2), 31.9 (C(10 )), 49.0 (C(20 )), 58.8 (N(CH2Ph)2), 79.8
(4H, m, C(3)H2, C(5)H2), 2.32 (2H, t, J 7.2, C(2)H2), 3.65 (3H, s, (C(5)), 82.8 (C(4)), 127.1, 128.4, 128.8 (o,m,p-Ph), 139.0 (i-Ph),
OMe), 4.05 (1H, dd, J 10.8, 7.2, C(50 )HA), 4.52 (1H, dd, J 10.8, 154.7 (C(2)); m/z (ESIþ) 362 ([M þ Na]þ, 100%); HRMS (ESIþ)
8.4, C(50 )HB), 4.66-4.73 (1H, m, C(40 )H); δC (100 MHz, CDCl3) C21H26NO3þ ([M þ H]þ) requires 340.1907; found 340.1911.
23.9, 24.3 (C(3), C(4), C(5)), 33.5 (C(2)), 51.6 (OMe), 69.3 (C(50 )), (RS,SR)-4-Butyl-5-methyl-1,3-dioxolan-2-one 43. Following
general procedure 1, 38 (71 mg, 0.72 mmol) in CH2Cl2 (4.8 mL)
(26) Kim, Y. J.; Barma, R. S. J. Org. Chem. 2005, 70, 7882.
was treated with Br3CCO2H (1.06 g, 3.61 mmol) and m-CPBA
(27) Matsumoto, K.; Fuwa, S.; Shimojo, M.; Kitajima, H. J. Chem. Soc. (250 mg, 75%, 1.08 mmol), followed by DBU (1.0 mL).
Jpn. 1996, 69, 2977. Purification via flash column chromatography (eluent 40-60 °C
4.15 (1H, dt, J 10.8, 3.8, C(6)H), 4.53 (2H, AB system, JAB 14.9, X-ray Crystal Structure Determination for 59. Data were collect-
NCH2Ph), 7.27-7.35 (5H, m, Ph); δC (100 MHz, CDCl3) 10.2 ed using an Enraf-Nonius κ-CCD diffractometer with graphite
(C(30 )), 21.2 (C(20 )), 24.9 (C(5)), 43.6 (C(4)), 52.5 (NCH2Ph), monochromated Mo KR radiation using standard procedures at
73.2 (C(10 )), 79.9 (C(6)), 127.7, 128.0, 128.7 (o,m,p-Ph), 136.5 150 K. The structure was solved by direct methods (SIR92); all
(i-Ph), 154.1 (CdO); m/z (ESI-) 248 ([M - H]-, 100%); HRMS non-hydrogen atoms were refined with anisotropic thermal
(ESI-) C14H18NO3- ([M - H]-) requires 248.1292; found parameters. Hydrogen atoms were added at idealized positions.
248.1291. The structure was refined using CRYSTALS.28
(RS,RS)-N(3)-Benzyl-5-(10 -hydroxybutyl)-1,3-oxazolidin-2-one X-ray crystal structure data for 61 [C14H19NO3]: M = 249.31,
58. Following general procedure 2, 56 (100 mg, 0.528 mmol) in monoclinic, space group P21/n, a = 12.0044(4) Å, b = 9.1663(4) Å,
CH2Cl2 (3.5 mL) was treated with Br3CCO2H (778 mg, 2.64 mmol) c = 12.0881(5) Å, β = 92.7130(18)°, V = 1328.63(9) Å3, Z = 4,
and m-CPBA (181 mg, 75%, 0.79 mmol), followed by DBU μ = 0.087 mm-1, colorless plate, crystal dimensions = 0.13
(1.0 mL). Purification via flash column chromatography (gradient 0.18 0.21 mm3. A total of 3016 unique reflections were
elution, 50%f100% EtOAc in 30-40 °C petrol) gave 58 as a measured for 5 < θ < 27, and 3016 reflections were used in
colorless oil (117 mg, 89%, >99:1 dr): νmax (film) 3418 (O-H), 2957 the refinement. The final parameters were wR2 = 0.141 and
(C-H), 1726 (CdO); δH (400 MHz, CDCl3) 0.92 (3H, t, J 7.1, R1 = 0.065 [I > -3.0σ(I)].
C(40 )H3), 1.39-1.54 (4H, m, C(20 )H2, C(30 )H2), 3.30 (1H, app t, J Crystallographic data (excluding structure factors) have been
7.5, C(4)HA), 3.41 (1H, app t, J 7.5, C(4)HB), 3.53-3.56 (1H, m, deposited with the Cambridge Crystallographic Data Centre as
C(10 )H), 4.36 (1H, d, J 15.0, NCHAHBPh), 4.36-4.38 (1H, m, supplementary publication number CCDC 784949. Copies of
C(5)H), 4.49 (1H, d, J 15.0, NCHAHBPh), 7.26-7.38 (5H, m, Ph); the data can be obtained, free of charge, on application to CCDC,
δC (100 MHz, CDCl3) 13.8 (C(40 )), 18.7 (C(30 )), 34.5 (C(20 )), 45.7 12 Union Road, Cambridge, CB2 1EZ, UK [fax: þ44(0)-1223-
(C(4)), 48.3 (NCH2Ph), 72.1 (C(10 )), 75.7 (C(5)), 127.9, 128.0, 128.8 336033 or e-mail: deposit@ccdc.cam.ac.uk].
(o,m,p-Ph), 135.6 (i-Ph), 157.7 (C(2)); m/z (ESIþ) 250 ([M þ H]þ, (RS,SR)-1-N,N-Dibenzylamino-1-phenyl-2,3-epoxy-3-methyl-
100%); HRMS (ESIþ) C14H20NO3þ ([M þ H]þ) requires 250.1438; butane 73. Cl3CCO2H (1.20 g, 7.33 mmol) was added to a solution
found 250.1436. of 67 (500 mg, 1.47 mmol) in CH2Cl2 (10 mL) at rt, and the
X-ray Crystal Structure Determination for 58. Data were solution was stirred for 30 min. m-CPBA (1.08 g, 70%, 4.40
collected using an Enraf-Nonius κ-CCD diffractometer with mmol) was added, and the solution was stirred at rt for 1 h. The
graphite monochromated Mo KR radiation using standard proce- mixture was then diluted with CH2Cl2 (20 mL) and washed with
dures at 150 K. The structure was solved by direct methods (SIR92); satd aq Na2SO3 (50 mL portions) until starch-iodide paper
all non-hydrogen atoms were refined with anisotropic thermal indicated that no m-CPBA was present. The organic layer was
parameters. Hydrogen atoms were added at idealized positions. washed with satd aq NaHCO3 (4 50 mL), dried, and con-
The structure was refined using CRYSTALS.28 centrated in vacuo. Purification via flash column chromatogra-
X-ray crystal structure data for 58 [C14H19NO3]: M = 498.62, phy (gradient elution, 1%f5% Et2O in 30-40 °C petrol) gave
triclinic, space group P1, a = 9.6645(4) Å, b = 11.3513(4) Å, 73 as a colorless oil (516 mg, 98%, >99:1 dr): νmax (film) 3041
c = 12.7583(5) Å, R = 101.4022(16)°, β = 104.9826(16)°, γ = (C-H), 2961 (C-H), 1493; δH (400 MHz, CDCl3) 0.91 (3H, s,
90.623(2)°, V = 1322.54(9) Å3, Z = 4, μ = 0.088 mm-1, Me), 1.45 (3H, s, Me), 3.34 (1H, d, J 9.0, C(2)H), 3.65 (1H, d, J
colorless block, crystal dimensions = 0.12 0.16 0.24 mm3. 9.0, C(1)H), 3.80 (4H, AB system, JAB 13.5, N(CH2Ph)2), 7.14-
A total of 5982 unique reflections were measured for 5 < θ < 27, 7.49 (15H, m, Ph); δC (100 MHz, CDCl3) 18.8 (Me), 24.8 (Me),
and 2904 reflections were used in the refinement. The final param- 53.9 (N(CH2Ph)2), 56.2 (C(3)), 60.3 (C(1)), 63.2 (C(2)), 126.7,
eters were wR2 = 0.134 and R1 = 0.127 [I > 2.5σ(I)]. 127.2, 127.8, 128.1, 128.3, 129.0 (o,m,p-Ph), 139.9, 140.0 (i-Ph);
Crystallographic data (excluding structure factors) have been m/z (ESIþ) 358 ([M þ H]þ, 100%); HRMS (ESIþ) C25H28NOþ
deposited with the Cambridge Crystallographic Data Centre as ([M þ H]þ) requires 358.2165; found 358.2167.
supplementary publication number CCDC 784948. Copies of (RS,SR)-1-N,N-Dibenzylamino-1-isopropyl-2,3-epoxy-3-methyl-
the data can be obtained, free of charge, on application to CCDC, butane 74. Cl3CCO2H (265 mg, 1.63 mmol) was added to a solu-
12 Union Road, Cambridge, CB2 1EZ, UK [fax: þ44(0)-1223- tion of 68 (100 mg, 0.33 mmol) in CH2Cl2 (2 mL) at rt, and the
336033 or e-mail: deposit@ccdc.cam.ac.uk]. solution was stirred for 30 min. m-CPBA (120 mg, 70%, 0.48
(RS,RS)-N(3)-Benzyl-6-(10 -hydroxypropyl)-1,3-oxazinan-2-one mmol) was added, and the solution was stirred at rt for 21 h. The
59. Following general procedure 2, 57 (120 mg, 0.630 mmol) in mixture was then diluted with CH2Cl2 (10 mL) and washed with
CH2Cl2 (4.2 mL) was treated with Br3CCO2H (932 mg, 3.15 satd aq Na2SO3 (20 mL portions) until starch-iodide paper
mmol) and m-CPBA (216 mg, 75%, 0.95 mmol), followed by indicated that no m-CPBA was present. The organic layer was
DBU (1.0 mL). Purification via flash column chromatography washed with satd aq NaHCO3 (4 20 mL), dried, and concen-
(gradient elution, 50%f100% EtOAc in 30-40 °C petrol) gave trated in vacuo. Purification via flash column chromatography
59 as a colorless oil (132 mg, 84%, >99:1 dr): C14H19NO3 (gradient elution, 1%f5% Et2O in 30-40 °C petrol) gave 73 as
requires C, 67.45; H, 7.7; N, 5.6%; found C, 67.4; H, 7.6; N, a white solid (105 mg, 99%, >99:1 dr): mp 74-77 °C; νmax (film)
5.6%; νmax (film) 3390 (O-H), 3031 (C-H), 2934 (C-H), 1681 2958 (C-H), 2927 (C-H), 1493; δH (400 MHz, CDCl3) 0.78
(CdO); δH (400 MHz, CDCl3) 0.99 (3H, t, J 7.0, C(30 )H3), (3H, d, J 6.7, MeCHMe), 1.02 (3H, d, J 6.7, MeCHMe), 1.15
1.53-1.64 (2H, m, C(20 )H2), 1.87-1.91 (2H, m, C(5)H2), 3.17- (3H, s, C(3)Me), 1.36 (3H, s, C(3)Me), 1.80-1.89 (1H, m,
3.22 (1H, m, C(4)HA), 3.21-3.30 (1H, m, C(4)HB), 3.49-3.53 CHMe2), 2.11 (1H, app t, J 9.8, C(1)H), 2.92 (1H, d, J 9.8,
(1H, m, C(10 )H), 4.11-4.16 (1H, m, C(6)H), 4.54 (2H, AB C(2)H), 3.90 (4H, AB system, JAB 13.1, N(CH2Ph)2), 7.20-7.49
system, JAB 15.0, NCH2Ph), 7.26-7.35 (5H, m, Ph); δC (100 (10H, m, Ph); δC (100 MHz, CDCl3) 19.5 (Me), 19.8 (Me), 20.9
MHz, CDCl3) 9.9 (C(30 )), 23.8 (C(20 )), 25.5 (C(5)), 43.7 (C(4)), (Me), 24.5 (Me), 28.8 (CHMe2), 54.7 (N(CH2Ph)2), 56.6 (C(3)),
52.5 (NCH2Ph), 74.2 (C(10 )), 79.8 (C(6)), 127.6, 128.1, 128.7 60.8 (C(1)), 66.3 (C(2)), 126.6, 128.0, 129.2 (o,m,p-Ph), 140.6
(o,m,p-Ph), 136.5 (i-Ph), 153.8 (C(2)); m/z (ESI-) 248 ([M-H]-, (i-Ph); m/z (ESIþ) 346 ([M þ Na]þ, 100%); HRMS (ESIþ)
100%); HRMS (ESI-) C14H18NO3- ([M-H]-) requires 248.1292; C22H30NOþ ([M þ H]þ) requires 324.2322; found 324.2325.
found 248.1292. X-ray Crystal Structure Determination for 74. Data were
collected using an Enraf-Nonius κ-CCD diffractometer with
(28) Betteridge, P. W.; Carruthers, J. R.; Cooper, R. I.; Prout, C. K.;
graphite monochromated Mo KR radiation using standard
Watkin, D. J. CRYSTALS; Chemical Crystallography Laboratory, Uni- procedures at 150 K. The structure was solved by direct
versity of Oxford: U.K., 2010; Issue 14. methods (SIR92); all non-hydrogen atoms were refined with
Acknowledgment. The authors would like to thank Aji- Supporting Information Available: Full details of all
nomoto Co., Inc. for funding (W.K.), the Oxford Chemical experimental procedures, characterization data, copies of
1
Crystallography Service for the use of their X-ray diffrac- H and 13C NMR spectra, and crystallographic information
tometers, Helen R. Storr for assistance with NMR experi- files (for structures CCDC 784948-784952). This material
ments, and Michael C. Willis and Robert H. Snell for is available free of charge via the Internet at http://pubs.
assistance with Chiral HPLC analysis. acs.org.